MENU
+Compare
XERI
Stock ticker: OTC
AS OF
Apr 17 closing price
Price
$0.01
Change
-$0.00 (-0.00%)
Capitalization
9.75M

XERI Xeriant, Inc. Forecast, Technical & Fundamental Analysis

Xeriant Inc is a holding and operating company focused on acquiring, developing, and commercializing revolutionary, eco-friendly technologies with applications in aerospace, including innovative aircraft concepts targeting emerging opportunities within the aviation industry... Show more

XERI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for XERI with price predictions
Apr 17, 2025

XERI's Stochastic Oscillator penetrates overbought zone

The Stochastic Oscillator for XERI moved into overbought territory on April 17, 2025. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on April 17, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on XERI as a result. In of 114 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 50-day moving average for XERI moved below the 200-day moving average on April 02, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XERI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for XERI entered a downward trend on April 17, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where XERI's RSI Indicator exited the oversold zone, of 20 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for XERI just turned positive on April 16, 2025. Looking at past instances where XERI's MACD turned positive, the stock continued to rise in of 61 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where XERI advanced for three days, in of 199 cases, the price rose further within the following month. The odds of a continued upward trend are .

XERI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (10.275). P/E Ratio (0.000) is within average values for comparable stocks, (56.512). XERI's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.150). Dividend Yield (0.000) settles around the average of (0.019) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (7.204).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. XERI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. XERI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 61, placing this stock worse than average.

View a ticker or compare two or three
XERI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Industry AerospaceDefense

Profile
Fundamentals
Details
Industry
N/A
Address
3998 FAU Boulevard
Phone
+1 561 491-9595
Employees
6
Web
https://www.xeriant.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME26.780.53
+2.02%
GameStop Corp
AAPL196.982.71
+1.39%
Apple
SPY526.410.75
+0.14%
SPDR® S&P 500® ETF
BTC.X85174.305000110.898440
+0.13%
Bitcoin cryptocurrency
TSLA241.37-0.18
-0.07%
Tesla

XERI and Stocks

Correlation & Price change

A.I.dvisor tells us that XERI and OBTEF have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XERI and OBTEF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XERI
1D Price
Change %
XERI100%
+0.68%
OBTEF - XERI
29%
Poorly correlated
N/A
TIKK - XERI
11%
Poorly correlated
N/A
NEXD - XERI
11%
Poorly correlated
N/A
MDALF - XERI
10%
Poorly correlated
-0.97%
SGGKY - XERI
5%
Poorly correlated
N/A
More